These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6529813)

  • 21. [Dissolution profiles of powdered inclusion compounds of sulfonamide drugs with beta-cyclodextrin].
    Chen JY; Tsai WY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1989 Apr; 5(4):206-11. PubMed ID: 2769826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stability test of chloramphenicol-beta-cyclodextrin-containing tablets].
    Szabó-Révész P; Pintye-Hódi K; Miseta M; Selmeczi B
    Pharmazie; 1988 Aug; 43(8):554-5. PubMed ID: 3237749
    [No Abstract]   [Full Text] [Related]  

  • 23. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
    Green AR; Guillory JK
    J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent.
    Tokumura T; Tsushima Y; Kayano M; Machida Y; Nagai T
    J Pharm Sci; 1985 Apr; 74(4):496-7. PubMed ID: 3999017
    [No Abstract]   [Full Text] [Related]  

  • 25. Different mode of prednisolone within alpha-, beta-, and gamma-cyclodextrins in aqueous solution and in solid state.
    Uekama K; Sakai A; Arimori K; Otagiri M; Saitô H
    Pharm Acta Helv; 1985; 60(4):117-21. PubMed ID: 4011623
    [No Abstract]   [Full Text] [Related]  

  • 26. High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex.
    Djedaïni F; Lin SZ; Perly B; Wouessidjewe D
    J Pharm Sci; 1990 Jul; 79(7):643-6. PubMed ID: 2398475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversed-phase high-performance liquid chromatographic separation of substituted phenolic compounds with a beta-cyclodextrin bonded phase column.
    Chang CA; Wu Q; Armstrong DW
    J Chromatogr; 1986 Feb; 354():454-8. PubMed ID: 3700535
    [No Abstract]   [Full Text] [Related]  

  • 28. Determination of association constants of beta-cyclodextrin and beta-cyclodextrin-bearing polymers with drugs by high-performance liquid chromatography.
    Sébille B; Thuaud N; Piquion J; Behar N
    J Chromatogr; 1987 Nov; 409():61-9. PubMed ID: 2826514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colorimetric determination of beta-cyclodextrin: two assay modifications based on molecular complexation of phenolphtalein.
    Mäkelä M; Korpela T; Laakso S
    J Biochem Biophys Methods; 1987 Apr; 14(2):85-92. PubMed ID: 3693795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxypropyl-beta-cyclodextrin derivatives: influence of average degree of substitution on complexing ability and surface activity.
    Müller BW; Brauns U
    J Pharm Sci; 1986 Jun; 75(6):571-2. PubMed ID: 3735101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved competitive indicator methods for the study of alpha-cyclodextrin complexes.
    Pendergast DD; Connors KA
    J Pharm Sci; 1984 Dec; 73(12):1779-83. PubMed ID: 6527255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of water structure on cyclodextrin inclusion and light sensitivity of epinephrine].
    Hüttenrauch R; Fricke S; Knop M
    Pharmazie; 1985 Mar; 40(3):199-200. PubMed ID: 4023038
    [No Abstract]   [Full Text] [Related]  

  • 33. Application of freezing point depression to drug interaction studies. I. Interaction between cyclodextrins and alcohols.
    Suzuki M; Ueda S; Kusai A
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):720-5. PubMed ID: 3409380
    [No Abstract]   [Full Text] [Related]  

  • 34. Complexation of several drugs with water-soluble cyclodextrin polymer.
    Szeman J; Ueda H; Szejtli J; Fenyvesi E; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):282-8. PubMed ID: 3594657
    [No Abstract]   [Full Text] [Related]  

  • 35. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cyclodextrins on sparingly soluble salts.
    Hirsch W; Fried V; Altman L
    J Pharm Sci; 1985 Oct; 74(10):1123-5. PubMed ID: 4078713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enrichment of enantiomers and other isomers with aqueous liquid membranes containing cyclodextrin carriers.
    Armstrong DW; Jin HL
    Anal Chem; 1987 Sep; 59(18):2237-41. PubMed ID: 3674440
    [No Abstract]   [Full Text] [Related]  

  • 38. Amorphous water-soluble derivatives of cyclodextrins: nontoxic dissolution enhancing excipients.
    Pitha J; Pitha J
    J Pharm Sci; 1985 Sep; 74(9):987-90. PubMed ID: 4067854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-cyclodextrin bonded silica for direct injection analysis of drug enantiomers in serum by liquid chromatography.
    Haginaka J; Wakai J
    Anal Chem; 1990 May; 62(10):997-1000. PubMed ID: 2163225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct liquid chromatographic separation of racemates with an alpha-cyclodextrin bonded phase.
    Armstrong DW; Yang XF; Han SM; Menges RA
    Anal Chem; 1987 Nov; 59(21):2594-6. PubMed ID: 3688447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.